Global Medical-grade Perfluorobutylpentane Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Medical-grade Perfluorobutylpentane Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Pharmaceutical Excipient Grade
- 1.3.3 Sterile Surgical Grade
- 1.3.4 Other
- 1.4 Market Analysis by Product Form
- 1.4.1 Overview: Global Medical-grade Perfluorobutylpentane Consumption Value by Product Form: 2021 Versus 2025 Versus 2032
- 1.4.2 Bulk Liquid
- 1.4.3 Sterile Single-use Vial
- 1.4.4 Other
- 1.5 Market Analysis by Application
- 1.5.1 Overview: Global Medical-grade Perfluorobutylpentane Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Ophthalmic Pharmaceutical Companies
- 1.5.3 Pharmaceutical CDMOs
- 1.5.4 Other
- 1.6 Global Medical-grade Perfluorobutylpentane Market Size & Forecast
- 1.6.1 Global Medical-grade Perfluorobutylpentane Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Medical-grade Perfluorobutylpentane Sales Quantity (2021-2032)
- 1.6.3 Global Medical-grade Perfluorobutylpentane Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Geuder
- 2.1.1 Geuder Details
- 2.1.2 Geuder Major Business
- 2.1.3 Geuder Medical-grade Perfluorobutylpentane Product and Services
- 2.1.4 Geuder Medical-grade Perfluorobutylpentane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Geuder Recent Developments/Updates
- 2.2 Siegfried
- 2.2.1 Siegfried Details
- 2.2.2 Siegfried Major Business
- 2.2.3 Siegfried Medical-grade Perfluorobutylpentane Product and Services
- 2.2.4 Siegfried Medical-grade Perfluorobutylpentane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Siegfried Recent Developments/Updates
- 2.3 HWI Group
- 2.3.1 HWI Group Details
- 2.3.2 HWI Group Major Business
- 2.3.3 HWI Group Medical-grade Perfluorobutylpentane Product and Services
- 2.3.4 HWI Group Medical-grade Perfluorobutylpentane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 HWI Group Recent Developments/Updates
- 2.4 Hengrui Pharma
- 2.4.1 Hengrui Pharma Details
- 2.4.2 Hengrui Pharma Major Business
- 2.4.3 Hengrui Pharma Medical-grade Perfluorobutylpentane Product and Services
- 2.4.4 Hengrui Pharma Medical-grade Perfluorobutylpentane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Hengrui Pharma Recent Developments/Updates
3 Competitive Environment: Medical-grade Perfluorobutylpentane by Manufacturer
- 3.1 Global Medical-grade Perfluorobutylpentane Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Medical-grade Perfluorobutylpentane Revenue by Manufacturer (2021-2026)
- 3.3 Global Medical-grade Perfluorobutylpentane Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Medical-grade Perfluorobutylpentane by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Medical-grade Perfluorobutylpentane Manufacturer Market Share in 2025
- 3.4.3 Top 6 Medical-grade Perfluorobutylpentane Manufacturer Market Share in 2025
- 3.5 Medical-grade Perfluorobutylpentane Market: Overall Company Footprint Analysis
- 3.5.1 Medical-grade Perfluorobutylpentane Market: Region Footprint
- 3.5.2 Medical-grade Perfluorobutylpentane Market: Company Product Type Footprint
- 3.5.3 Medical-grade Perfluorobutylpentane Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Medical-grade Perfluorobutylpentane Market Size by Region
- 4.1.1 Global Medical-grade Perfluorobutylpentane Sales Quantity by Region (2021-2032)
- 4.1.2 Global Medical-grade Perfluorobutylpentane Consumption Value by Region (2021-2032)
- 4.1.3 Global Medical-grade Perfluorobutylpentane Average Price by Region (2021-2032)
- 4.2 North America Medical-grade Perfluorobutylpentane Consumption Value (2021-2032)
- 4.3 Europe Medical-grade Perfluorobutylpentane Consumption Value (2021-2032)
- 4.4 Asia-Pacific Medical-grade Perfluorobutylpentane Consumption Value (2021-2032)
- 4.5 South America Medical-grade Perfluorobutylpentane Consumption Value (2021-2032)
- 4.6 Middle East & Africa Medical-grade Perfluorobutylpentane Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 5.2 Global Medical-grade Perfluorobutylpentane Consumption Value by Type (2021-2032)
- 5.3 Global Medical-grade Perfluorobutylpentane Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 6.2 Global Medical-grade Perfluorobutylpentane Consumption Value by Application (2021-2032)
- 6.3 Global Medical-grade Perfluorobutylpentane Average Price by Application (2021-2032)
7 North America
- 7.1 North America Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 7.2 North America Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 7.3 North America Medical-grade Perfluorobutylpentane Market Size by Country
- 7.3.1 North America Medical-grade Perfluorobutylpentane Sales Quantity by Country (2021-2032)
- 7.3.2 North America Medical-grade Perfluorobutylpentane Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 8.2 Europe Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 8.3 Europe Medical-grade Perfluorobutylpentane Market Size by Country
- 8.3.1 Europe Medical-grade Perfluorobutylpentane Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Medical-grade Perfluorobutylpentane Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Medical-grade Perfluorobutylpentane Market Size by Region
- 9.3.1 Asia-Pacific Medical-grade Perfluorobutylpentane Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Medical-grade Perfluorobutylpentane Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 10.2 South America Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 10.3 South America Medical-grade Perfluorobutylpentane Market Size by Country
- 10.3.1 South America Medical-grade Perfluorobutylpentane Sales Quantity by Country (2021-2032)
- 10.3.2 South America Medical-grade Perfluorobutylpentane Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical-grade Perfluorobutylpentane Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Medical-grade Perfluorobutylpentane Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Medical-grade Perfluorobutylpentane Market Size by Country
- 11.3.1 Middle East & Africa Medical-grade Perfluorobutylpentane Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Medical-grade Perfluorobutylpentane Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Medical-grade Perfluorobutylpentane Market Drivers
- 12.2 Medical-grade Perfluorobutylpentane Market Restraints
- 12.3 Medical-grade Perfluorobutylpentane Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Medical-grade Perfluorobutylpentane and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Medical-grade Perfluorobutylpentane
- 13.3 Medical-grade Perfluorobutylpentane Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Medical-grade Perfluorobutylpentane Typical Distributors
- 14.3 Medical-grade Perfluorobutylpentane Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Medical-grade Perfluorobutylpentane market size was valued at US$ 28.60 million in 2025 and is forecast to a readjusted size of US$ 50.96 million by 2032 with a CAGR of 8.0% during review period.
Medical-grade perfluorobutylpentane, commonly referred to as F4H5, is a clear and colorless semifluorinated alkane composed of a perfluorobutyl segment and a pentyl segment. Its low surface tension, strong spreading properties, amphiphilic character, and ability to dissolve silicone oil and selected lipophilic drugs make it suitable primarily as a water-free ophthalmic drug-delivery vehicle and as a sterile medical liquid for removing silicone oil residues and cleaning intraocular lenses during vitreoretinal procedures. Key upstream inputs include high-purity fluorinated organic intermediates, carbon-chain coupling materials, high-purity solvents and process gases, together with distillation and purification capacity, trace-impurity control, sterile filtration, cleanroom filling, and pharmaceutical packaging components. Major downstream customers include ophthalmic pharmaceutical companies, ophthalmic medical-device manufacturers, sterile drug-product CDMOs, hospitals, and specialist eye centers. Under the narrow medical-material scope, estimated global effective capacity was approximately 2,600 kg/yr in 2025, while sales volume was approximately 1,763 kg, corresponding to capacity utilization of about 67.8%. The weighted average ex-factory price was approximately USD 15,768 per kg, and the typical industry gross margin ranged from 40% to 60%.
The global medical-grade perfluorobutylpentane market remains a highly specialized ophthalmic materials segment characterized by a small number of qualified suppliers, a limited commercial product portfolio, and substantial technical and regulatory barriers. Current commercial demand is concentrated in two principal routes: pure F4H5 surgical washout liquids and water-free cyclosporine ophthalmic solutions. The value chain is divided among technology owners, raw-material suppliers, sterile formulation manufacturers, CDMOs, marketing authorization holders, and commercial distributors. The synthesis process, impurity profile, and pharmaceutical quality documentation for F4H5 are generally confidential, and changing the excipient source in an approved drug may require additional quality, stability, and regulatory comparability work. Suppliers already qualified within approved ophthalmic products therefore benefit from meaningful switching barriers and durable customer relationships. The principal demand driver is the geographic expansion of water-free ophthalmic drug-delivery technology. F4H5 can dissolve hydrophobic compounds such as cyclosporine and enables a clear, non-aqueous ophthalmic solution without conventional surfactants or antimicrobial preservatives. VEVYE is commercially available in the United States, Vevizye has been approved in the European Union, and Heng Yi received approval in China in 2026. These developments are shifting F4H5 from a narrowly used vitreoretinal surgical material toward a pharmaceutical excipient with commercial demand across several major healthcare markets. Future growth will depend primarily on prescription adoption, European and Chinese launches, and the ability of EyeSol-type platforms to deliver additional lipophilic ophthalmic drugs, rather than solely on growth in silicone-oil removal procedures. Technology development will increasingly focus on high-purity manufacturing, control of fluorinated process impurities, extremely low moisture levels, sterility assurance, and compatibility with primary packaging rather than on nominal assay alone. The FDA quality review of the F4H5-containing cyclosporine product addressed identity, related substances, visible and sub-visible particles, sterility, and extractables and leachables from the container-closure system, demonstrating that commercialization requires integrated development of the material, formulation, filling process, and packaging. F4H5 may also be evaluated as a carrier for tacrolimus, anti-inflammatory agents, glaucoma therapies, and other poorly water-soluble ophthalmic compounds. However, translation from laboratory research to commercial products will require formulation stability, ocular tolerability, long-term safety, and scalable non-aqueous sterile filling. CDMOs combining analytical, sterile manufacturing, and ophthalmic packaging capabilities are therefore expected to become increasingly important. Major constraints include the small overall demand base, concentrated supply, limited transparency regarding excipient sourcing, long pharmaceutical development timelines, and increasing scrutiny of environmentally persistent fluorinated substances. The EMA concluded that available non-clinical data did not indicate a particular human safety hazard from the perfluorobutylpentane excipient, but its environmental assessment identified a potential for persistence. Future requirements covering manufacturing emissions, waste-liquid management, product disposal, and fluorinated-substance regulation may therefore increase compliance costs. F4H5-based products must also compete with conventional cyclosporine emulsions, alternative anti-inflammatory eye drops, and other dry-eye treatment mechanisms. The market is consequently more likely to expand steadily around a small number of high-value ophthalmic applications than to develop into a high-volume commodity chemical sector, favoring suppliers with complete regulatory documentation, secure long-term supply, and credible environmental management systems.
This report is a detailed and comprehensive analysis for global Medical-grade Perfluorobutylpentane market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical-grade Perfluorobutylpentane market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical-grade Perfluorobutylpentane market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical-grade Perfluorobutylpentane market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Medical-grade Perfluorobutylpentane market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical-grade Perfluorobutylpentane
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical-grade Perfluorobutylpentane market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Geuder, Siegfried, HWI Group, Hengrui Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical-grade Perfluorobutylpentane market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pharmaceutical Excipient Grade
Sterile Surgical Grade
Other
Market segment by Product Form
Bulk Liquid
Sterile Single-use Vial
Other
Market segment by Application
Ophthalmic Pharmaceutical Companies
Pharmaceutical CDMOs
Other
Major players covered
Geuder
Siegfried
HWI Group
Hengrui Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical-grade Perfluorobutylpentane product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical-grade Perfluorobutylpentane, with price, sales quantity, revenue, and global market share of Medical-grade Perfluorobutylpentane from 2021 to 2026.
Chapter 3, the Medical-grade Perfluorobutylpentane competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical-grade Perfluorobutylpentane breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical-grade Perfluorobutylpentane market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical-grade Perfluorobutylpentane.
Chapter 14 and 15, to describe Medical-grade Perfluorobutylpentane sales channel, distributors, customers, research findings and conclusion.